| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |